OXYBUTYNIN CHLORIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
64980-679 -
Package NDC
64980-679-01 -
Package NDC
64980-679-10 -
Package NDC
64980-679-50 -
Application number
ANDA209025 -
SPL ID
df6a21bf-5578-40a0-9d60-e963e18e1beb -
SPL set ID
9578b6b8-5b9d-4263-9142-39b2c7216b85 -
UNII
L9F3D9RENQ -
RxCUI
863664 -
RxCUI
863758
What the source publishes
- Labeler
- RISING PHARMA HOLDINGS, INC.
- Active ingredients
- OXYBUTYNIN CHLORIDE
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "OXYBUTYNIN CHLORIDE",
"splId": "df6a21bf-5578-40a0-9d60-e963e18e1beb",
"labels": [
{
"setId": "9578b6b8-5b9d-4263-9142-39b2c7216b85",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9578b6b8-5b9d-4263-9142-39b2c7216b85",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9578b6b8-5b9d-4263-9142-39b2c7216b85"
}
],
"routes": [
"ORAL"
],
"labeler": "RISING PHARMA HOLDINGS, INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (64980-679-01)",
"package_ndc": "64980-679-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20260718"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (64980-679-10)",
"package_ndc": "64980-679-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20260427"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (64980-679-50)",
"package_ndc": "64980-679-50",
"identifierStatus": "well-formed",
"marketing_start_date": "20260427"
}
],
"productId": "64980-679_df6a21bf-5578-40a0-9d60-e963e18e1beb",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "64980-679",
"deaSchedule": null,
"genericName": "OXYBUTYNIN CHLORIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "OXYBUTYNIN CHLORIDE",
"strength": "5 mg/1"
}
],
"applicationNumber": "ANDA209025",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260427",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0364980679107",
"0364980679015"
],
"unii": [
"L9F3D9RENQ"
],
"rxcui": [
"863664",
"863758"
],
"spl_set_id": [
"9578b6b8-5b9d-4263-9142-39b2c7216b85"
],
"manufacturer_name": [
"RISING PHARMA HOLDINGS, INC."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:64980-679_df6a21bf-5578-40a0-9d60-e963e18e1beb"